Contract HT009025FG0830105
Phadia Us Inc · Department Of Defense · July 23, 2025
Phadia Us Inc was awarded a federal contract by Department Of Defense (Defense Health Agency) on July 23, 2025 for $50,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Portage, MI. This is a task or delivery order issued under parent IDIQ FA301624A0046. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- HT009025FG0830105
- Parent IDIQ
- FA301624A0046
- Award type
- Bpa Call
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- Place of performance
- Portage, MI
- First action
- July 23, 2025
Description
REAGENT IS REQUIRED TO PERFORM ALLERGY TESTING WHICH PROVIDES HEALTHCARE PROVIDERS WITH CRITICAL INFORMATION IN THE DETECTION/MANAGEMENT OF ALLERGIC REACTIONS FOR THE SAN ANTONIO MARKET AND 153 OTHER MILITARY TREATMENT FACILITIES.
Modification timeline
-
July 23, 2025Base award$49.9K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Diasorin Inc | Department Of Defense | December 31, 2025 | $518.8K |
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Immucor Inc | Department Of Defense | December 31, 2025 | $154.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HT009025FG0830105?
Contract HT009025FG0830105 is a federal contract awarded to Phadia Us Inc by Department Of Defense on July 23, 2025 for $50,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 0 times since the base award.
Who won contract HT009025FG0830105?
Phadia Us Inc won contract HT009025FG0830105 from Department Of Defense.
How much is contract HT009025FG0830105 worth?
Contract HT009025FG0830105 has obligated $50,000 to date.